Epitalon
A Russian-born "bioregulator" peptide investigated for its potential to lengthen telomeres and extend lifespan.
What it is
Epitalon is a synthetic tetrapeptide composed of only four amino acids (Ala-Glu-Asp-Gly). It is a synthetic version of "Epithalamin," a substance naturally produced in the pineal gland. It was originally developed in the 1980s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia.
We view Epitalon as a "master regulator." It is part of a class of peptides called "bioregulators" that are thought to act like light switches, turning on certain genes that have become "dim" as we age.
What it does
The most famous claim about Epitalon is its ability to stimulate the production of telomerase. Telomerase is the enzyme that maintains and repairs telomeres—the protective caps on the ends of our chromosomes. As our cells divide, telomeres get shorter; once they are gone, the cell dies. By activating telomerase, Epitalon is thought to delay this cellular aging process.
Beyond telomeres, research suggests it helps regulate the production of melatonin, which improves sleep-wake cycles, and acts as a powerful antioxidant. Users often pursue it for its purported "whole-body" anti-aging effects, including better sleep, improved skin quality, and increased energy levels.
What the evidence says
Most of the research on Epitalon was conducted in Russia over several decades. These studies, including long-term observations of elderly patients, reported significant reductions in mortality and age-related diseases. Animal studies have also shown increased lifespans in rats and fruit flies.
However, many Western scientists view these results with caution because the studies often lacked the rigorous, multi-center, double-blind protocols required by the FDA. While the mechanism of telomerase activation is biologically plausible, large-scale independent human trials in the US have yet to be conducted to confirm the Russian findings.
What it costs
Epitalon is typically sold in 10mg or 50mg vials. A 10mg vial usually costs between $30 and $50. Because longevity protocols often involve a high-dose "cycle" once or twice a year, the total annual research cost can range from $200 to $500.
Side effects and risks
Epitalon is generally reported to have a very high safety profile with almost no reported side effects in the literature. However, the theoretical risk of telomerase activation is that it could potentially help cancer cells (which also use telomerase to stay "immortal") grow more quickly. For this reason, many researchers suggest avoiding it if there is a history of malignancy.
In April 2026, the FDA removed Epitalon from the Category 2 bulk substances list and scheduled it for PCAC review (July 24, 2026) for possible 503A inclusion. Compounding remains restricted in the meantime.
Where users source it
In the US, Epitalon is sold strictly as a research chemical. Quality control is vital, as the peptide is very small and must be synthesized with high precision. We suggest sourcing from labs that provide clear evidence of their manufacturing standards and batch purity.
Sources
- Anisimov VN, et al. (2001). "Epithalon: a peptide that increases the maximum lifespan." Annals of the New York Academy of Sciences. PMID 11441840
- Khavinson VKh, et al. (2003). "Peptides and Ageing." Neuro Endocrinology Letters. PMID 14502102
- SSRP Institute. (April 2026). "FDA Announces Change in Status of 12 Peptides."
- Frier Levitt. (April 2026). "FDA to Remove 12 Popular Peptides from Do-Not-Compound List."
A natural copper-binding peptide that serves as the "gold standard" for skin regeneration and hair health.
Often called the "Body Protection Compound," this gastric-derived peptide is a staple in recovery research circles.
A synthetic fragment of a natural protein that acts as a cellular "repair manual" for muscles and skin.